Sign in

CIK 0001124524

  • Accelerated filer

Cryoport, Inc.

Sign in to watch
Ticker
CYRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
880313393
Phone
+1 949-232-1900
Business address
112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
Former names
CRYOPORT SYSTEMS INC
  1. 4 Exercise or conversion Chief Financial Officer acquired 16,000 shares (option exercise)
  2. 4 Grant or award Director acquired 8,105 shares (grant or award)
  3. 4 Grant or award Director acquired 8,105 shares (grant or award)
  4. 4 Grant or award Director acquired 8,105 shares (grant or award)
  5. 4 Grant or award Director acquired 8,105 shares (grant or award)
  6. 4 Grant or award Director acquired 8,105 shares (grant or award)
  7. 4 Grant or award Director acquired 8,105 shares (grant or award)
  8. 4 Open-market sale Director sold 7,203 shares at $21.51 ($154,906)
  9. 4 Open-market sale President, CEO sold 141,159 shares at $21.63 ($3,053,509)
  10. 4 Planned sale Chief Financial Officer sold 19,918 shares at $21.94 ($437,023)
  11. 4 Grant or award Chief Financial Officer acquired 10,455 shares (grant or award)
  12. 4 Grant or award Chief Executive Officer acquired 27,092 shares (grant or award)
  13. 4 Grant or award Chief Scientific Officer acquired 10,455 shares (grant or award)
  14. 4 Exercise or conversion Director acquired 1,111 shares (option exercise)
  15. 4 Open-market sale Chief Scientific Officer sold 1,362 shares at $20.79 ($28,316)
  16. 4 Open-market sale Chief Executive Officer sold 2,599 shares at $20.79 ($54,033)
  17. 4 Open-market sale Chief Financial Officer sold 1,069 shares at $20.79 ($22,225)
  18. 4 Open-market sale Chief Financial Officer sold 1,159 shares at $20.14 ($23,342)
  19. 4 Open-market sale Chief Scientific Officer sold 1,476 shares at $20.14 ($29,727)
  20. 4 Open-market sale Chief Executive Officer sold 3,798 shares at $20.14 ($76,492)

Page 5 of 20 · 392 filings